Evidence map›Paper›PMID 19461888›Full record

ArticlePLoS pathogens2009

Activation of human monocytes by live Borrelia burgdorferi generates TLR2-dependent and -independent responses which include induction of IFN-beta.

Juan C Salazar, Star Duhnam-Ems, Carson La Vake, Adriana R Cruz, Meagan W Moore, Melissa J Caimano, Leonor Velez-Climent, Jonathan Shupe, Winfried Krueger, Justin D Radolf

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 100 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed, 2 pooled it
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

100 citing papers in PubMed, 2 syntheses or guidelines pooled it, 160 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Trial
  4. Article
  5. Glycolytic reprogramming in host response toExperimental and therapeutic medicine · 2026
    Article
  6. Type I interferon signaling promotes early innate control ofbioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Impact ofFrontiers in immunology · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Inhibition ofInternational journal of molecular sciences · 2022
    Article

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Juan C SalazarConnecticut Children's Medical Center, Division of Pediatric Infectious Diseases, Hartford, Connecticut, USA.
Star Duhnam-Ems
Carson La Vake
Adriana R Cruz
Meagan W Moore
Melissa J Caimano
Leonor Velez-Climent
Jonathan Shupe
Winfried Krueger
Justin D Radolf
UConn Health · USCentro Internacional de Entrenamiento e Investigaciones Medicas · COConnecticut Children's Medical Center · US

Funding

ZONISAMIDE VERSUS PLACEBOM01RR006192 · NCRR · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI DRAZINIC, CAROLYN M · 1994 to 2008
$22.1M
RpoS Regulation of Borrelia burgdorferi Genes in vivoR01AI029735 · NIAID · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI CAIMANO, MELISSA J, RADOLF, JUSTIN D · 1990 to 2022
$10.7M
CUTANEOUS IMMUNE RESPONSE IN SECONDARY SYPHILISR01AI038894 · NIAID · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI RADOLF, JUSTIN D · 1996 to 2005
$2.1M
RpoS Regulation of Borrelia burgdorferi Genes in vivoR56AI029735 · NIAID · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI RADOLF, JUSTIN D · 2012 to 2012
$536k
Immunity in Early Syphillis: Pathway to HIV CoinfectionK23AI062439 · NIAID · CONNECTICUT CHILDREN'S MEDICAL CENTER · PI SALAZAR, JUAN C · 2005 to 2007
$454k
NCRR NIH HHS M01 RR006192NCRR NIH HHS M01RR006192NIAID NIH HHS 1 K23 AI62439-01A1NIAID NIH HHS AI-29735NIAID NIH HHS AI-38894NIAID NIH HHS K23 AI062439NIAID NIH HHS R01 AI029735NIAID NIH HHS R01 AI038894NIAID NIH HHS R56 AI029735
6 · The paper itself

Abstract

It is widely believed that innate immune responses to Borrelia burgdorferi (Bb) are primarily triggered by the spirochete's outer membrane lipoproteins signaling through cell surface TLR1/2. We recently challenged this notion by demonstrating that phagocytosis of live Bb by peripheral blood mononuclear cells (PBMCs) elicited greater production of proinflammatory cytokines than did equivalent bacterial lysates. Using whole genome microarrays, we show herein that, compared to lysates, live spirochetes elicited a more intense and much broader transcriptional response involving genes associated with diverse cellular processes; among these were IFN-beta and a number of interferon-stimulated genes (ISGs), which are not known to result from TLR2 signaling. Using isolated monocytes, we demonstrated that cell activation signals elicited by live Bb result from cell surface interactions and uptake and degradation of organisms within phagosomes. As with PBCMs, live Bb induced markedly greater transcription and secretion of TNF-alpha, IL-6, IL-10 and IL-1beta in monocytes than did lysates. Secreted IL-18, which, like IL-1beta, also requires cleavage by activated caspase-1, was generated only in response to live Bb. Pro-inflammatory cytokine production by TLR2-deficient murine macrophages was only moderately diminished in response to live Bb but was drastically impaired against lysates; TLR2 deficiency had no significant effect on uptake and degradation of spirochetes. As with PBMCs, live Bb was a much more potent inducer of IFN-beta and ISGs in isolated monocytes than were lysates or a synthetic TLR2 agonist. Collectively, our results indicate that the enhanced innate immune responses of monocytes following phagocytosis of live Bb have both TLR2-dependent and -independent components and that the latter induce transcription of type I IFNs and ISGs.

Indexed as

AdultAnimalsBacteriolysisBorrelia burgdorferiBorrelia InfectionsCells, CulturedCytokinesFemaleGene Expression ProfilingGene Expression RegulationHumansInterferon-betaInterleukin-18MacrophagesMaleMiceCytokinesInterferon-betaInterleukin-18TLR5 protein, humanToll-Like Receptor 2Toll-Like Receptor 5

Identifiers

PMID19461888
PMCPMC2679197
OpenAlexW2078342014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.